Mesenchymal stem cells: Molecular characteristics and clinical applications
- PMID: 21607123
- PMCID: PMC3097925
- DOI: 10.4252/wjsc.v2.i4.67
Mesenchymal stem cells: Molecular characteristics and clinical applications
Abstract
Mesenchymal stem cells (MSCs) are non-hematopoietic stem cells with the capacity to differentiate into tissues of both mesenchymal and non-mesenchymal origin. MSCs can differentiate into osteoblastic, chondrogenic, and adipogenic lineages, although recent studies have demonstrated that MSCs are also able to differentiate into other lineages, including neuronal and cardiomyogenic lineages. Since their original isolation from the bone marrow, MSCs have been successfully harvested from many other tissues. Their ease of isolation and ex vivo expansion combined with their immunoprivileged nature has made these cells popular candidates for stem cell therapies. These cells have the potential to alter disease pathophysiology through many modalities including cytokine secretion, capacity to differentiate along various lineages, immune modulation and direct cell-cell interaction with diseased tissue. Here we first review basic features of MSC biology including MSC characteristics in culture, homing mechanisms, differentiation capabilities and immune modulation. We then highlight some in vivo and clinical evidence supporting the therapeutic roles of MSCs and their uses in orthopedic, autoimmune, and ischemic disorders.
Keywords: Autoimmune disease; Autologous transplant; Bone marrow stem cell; Cell-based therapy; Mesenchymal stem cells; Mesenchymal stromal cell; Therapeutic application.
Figures
Similar articles
-
Matrix-mediated retention of adipogenic differentiation potential by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion.Biomaterials. 2005 Nov;26(31):6167-75. doi: 10.1016/j.biomaterials.2005.03.024. Biomaterials. 2005. PMID: 15913765
-
Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages.J Hematother Stem Cell Res. 2000 Dec;9(6):841-8. doi: 10.1089/152581600750062264. J Hematother Stem Cell Res. 2000. PMID: 11177595
-
Comparative analysis of human mesenchymal stem cells from bone marrow and adipose tissue under xeno-free conditions for cell therapy.Stem Cell Res Ther. 2015 Apr 13;6(1):55. doi: 10.1186/s13287-015-0066-5. Stem Cell Res Ther. 2015. PMID: 25884704 Free PMC article.
-
Therapeutic potential of adult bone marrow-derived mesenchymal stem cells in diseases of the skeleton.J Cell Biochem. 2010 Oct 1;111(2):249-57. doi: 10.1002/jcb.22701. J Cell Biochem. 2010. PMID: 20506559 Free PMC article. Review.
-
Bio-mimicking Shear Stress Environments for Enhancing Mesenchymal Stem Cell Differentiation.Curr Stem Cell Res Ther. 2020;15(5):414-427. doi: 10.2174/1574888X15666200408113630. Curr Stem Cell Res Ther. 2020. PMID: 32268869 Review.
Cited by
-
Adipose-derived mesenchymal stem cells (MSCs) are a superior cell source for bone tissue engineering.Bioact Mater. 2023 Dec 14;34:51-63. doi: 10.1016/j.bioactmat.2023.12.003. eCollection 2024 Apr. Bioact Mater. 2023. PMID: 38186960 Free PMC article.
-
Combination of human platelet lysate and 3D gelatin scaffolds to enhance osteogenic differentiation of human amniotic fluid derived mesenchymal stem cells.Heliyon. 2023 Jul 24;9(8):e18599. doi: 10.1016/j.heliyon.2023.e18599. eCollection 2023 Aug. Heliyon. 2023. PMID: 37576189 Free PMC article.
-
The effects of IL-1β stimulated human umbilical cord mesenchymal stem cells on polarization and apoptosis of macrophages in rheumatoid arthritis.Sci Rep. 2023 Jun 30;13(1):10612. doi: 10.1038/s41598-023-37741-6. Sci Rep. 2023. PMID: 37391581 Free PMC article.
-
Induced pluripotent stem cell-based therapies for organ fibrosis.Front Bioeng Biotechnol. 2023 May 18;11:1119606. doi: 10.3389/fbioe.2023.1119606. eCollection 2023. Front Bioeng Biotechnol. 2023. PMID: 37274156 Free PMC article. Review.
-
Engineered nucleus-free mesenchymal stem cells (MSCs) for the targeted delivery of therapeutics to disease site.Genes Dis. 2022 Sep 14;10(2):310-312. doi: 10.1016/j.gendis.2022.09.001. eCollection 2023 Mar. Genes Dis. 2022. PMID: 37223510 Free PMC article. No abstract available.
References
-
- Deng ZL, Sharff KA, Tang N, Song WX, Luo J, Luo X, Chen J, Bennett E, Reid R, Manning D, et al. Regulation of osteogenic differentiation during skeletal development. Front Biosci. 2008;13:2001–2021. - PubMed
-
- Friedenstein AJ, Petrakova KV, Kurolesova AI, Frolova GP. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation. 1968;6:230–247. - PubMed
-
- Luu HH, Song WX, Luo X, Manning D, Luo J, Deng ZL, Sharff KA, Montag AG, Haydon RC, He TC. Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells. J Orthop Res. 2007;25:665–677. - PubMed
-
- Young HE. Existence of reserve quiescent stem cells in adults, from amphibians to humans. Curr Top Microbiol Immunol. 2004;280:71–109. - PubMed
-
- D'Ippolito G, Diabira S, Howard GA, Roos BA, Schiller PC. Low oxygen tension inhibits osteogenic differentiation and enhances stemness of human MIAMI cells. Bone. 2006;39:513–522. - PubMed
LinkOut - more resources
Full Text Sources
